Alta Fundamental Advisers LLC 13D and 13G filings for Milestone Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-07-16 6:06 pm Purchase |
2024-07-14 | 13D | Milestone Pharmaceuticals Inc. MIST |
Alta Fundamental Advisers LLC | 2,658,589 4.990% |
987,300 (+59.07%) |
Filing |
| 2023-11-09 4:43 pm Purchase |
2023-11-06 | 13D | Milestone Pharmaceuticals Inc. MIST |
Alta Fundamental Advisers LLC | 1,671,289 5.000% |
1,671,289 (New Position) |
Filing |